DAKLINZA FDA approval date
The FDA approved DAKLINZA on 24 Jul 2015.
- FDA approval date
- 24 Jul 2015
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DACLATASVIR DIHYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2015-07-24Day | DAKLINZA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206843", "applicant_as_listed_by_fda": "BRISTOL-MYERS SQUIBB", "brand_names": ["DAKLINZA"], "active_ingredients": ["DACLATASVIR DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |